[Skip to Content]
[Skip to Content Landing]
Views 1,796
Citations 0
Editorial
July 2017

Disclosing the Conflicts of Interest of US Food and Drug Administration Advisory Committee Members

Author Affiliations
  • 1Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut
  • 2Editor at Large, JAMA Internal Medicine
JAMA Intern Med. 2017;177(7):919. doi:10.1001/jamainternmed.2017.2093

In this issue of JAMA Internal Medicine, Xu and colleagues1 at the US Food and Drug Administration (FDA) report on the conflicts of interest of the voting members of the agency’s advisory committees. The agency excludes many individuals because of conflicts of interest; it may, however, determine that the advantages of a conflicted member’s participation outweigh the disadvantages. Advisory committees are by their nature advisory; the FDA makes the final decisions.2,3

First Page Preview View Large
First page PDF preview
First page PDF preview
×